×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PGEN – precigen, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High |
2.17
02/19/25
|
| 52 Week Low |
0.6513
12/17/24
|
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PGEN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/16
08:20 am
pgen
Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th [Yahoo! Finance]
Medium
Report
Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th [Yahoo! Finance]
4/16
08:05 am
pgen
Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th
Medium
Report
Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th
3/27
08:04 pm
pgen
Is Precigen (PGEN) The Hot Biotech Stock Under $5? [Yahoo! Finance]
Medium
Report
Is Precigen (PGEN) The Hot Biotech Stock Under $5? [Yahoo! Finance]
3/20
08:05 am
pgen
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Medium
Report
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
3/19
04:05 pm
pgen
Precigen Reports Full Year 2024 Financial Results and Business Updates
Low
Report
Precigen Reports Full Year 2024 Financial Results and Business Updates
3/13
08:05 am
pgen
Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th
Medium
Report
Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th
3/6
07:29 am
pgen
Orbital Therapeutics Appoints Geno Germano, Biopharma Veteran, to its Board of Directors [Yahoo! Finance]
Low
Report
Orbital Therapeutics Appoints Geno Germano, Biopharma Veteran, to its Board of Directors [Yahoo! Finance]
2/25
09:57 am
pgen
Maryland Tech Council Announces Finalists for 2025 ICON Awards [Yahoo! Finance]
Low
Report
Maryland Tech Council Announces Finalists for 2025 ICON Awards [Yahoo! Finance]
Date
Time
Symbol
Headline
Impact
3/19
04:31 pm
pgen
Form 10-K PRECIGEN, INC. For: Dec 31
Medium
Report
Form 10-K PRECIGEN, INC. For: Dec 31
3/19
04:22 pm
pgen
Form 8-K PRECIGEN, INC. For: Mar 19
Medium
Report
Form 8-K PRECIGEN, INC. For: Mar 19
3/17
06:38 pm
pgen
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: KIRK RANDAL J
Low
Report
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: KIRK RANDAL J
3/17
06:36 pm
pgen
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: AGEE NANCY H
Low
Report
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: AGEE NANCY H
3/17
06:34 pm
pgen
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: Gupta Vinita D
Low
Report
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: Gupta Vinita D
3/17
06:33 pm
pgen
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: Hassan Fred
Low
Report
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: Hassan Fred
3/17
06:32 pm
pgen
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: Turley James S
Low
Report
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: Turley James S
3/17
06:30 pm
pgen
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: KINDLER JEFFREY B
Low
Report
Form 4 PRECIGEN, INC. For: Mar 13 Filed by: KINDLER JEFFREY B
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/23
Form 4 PRECIGEN, INC. For: Mar 23 Filed by: Sterling Rick L.
31.6%
4/20 Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors 20.3%
3/17 Form 4 PRECIGEN, INC. For: Mar 13 Filed by: ALVAREZ CESAR L 11.6%
3/3 Form 4 PRECIGEN, INC. For: Feb 28 Filed by: KIRK RANDAL J 8.4%
4/29 Form DEFA14A PRECIGEN, INC. 5.7%
3/1 Precigen Q4 Earnings Preview [Seeking Alpha] 3.2%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: Lehr Donald P. 2.9%
2/11 Form D PRECIGEN, INC. 1.0%
4/20 Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse™ Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors 20.3%
3/17 Form 4 PRECIGEN, INC. For: Mar 13 Filed by: ALVAREZ CESAR L 11.6%
3/3 Form 4 PRECIGEN, INC. For: Feb 28 Filed by: KIRK RANDAL J 8.4%
4/29 Form DEFA14A PRECIGEN, INC. 5.7%
3/1 Precigen Q4 Earnings Preview [Seeking Alpha] 3.2%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: Lehr Donald P. 2.9%
2/11 Form D PRECIGEN, INC. 1.0%
TOP News Decliners
3/20
Form 4 PRECIGEN, INC. For: Mar 19 Filed by: KIRK RANDAL J
-22.7%
3/2 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.250 ActVsEst (0.220) - Miss -17.1%
3/10 Form 4 PRECIGEN, INC. For: Mar 08 Filed by: Turley James S -7.6%
3/17 Precigen (NASDAQ: PGEN) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.8%
2/24 Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd -4.6%
2/6 Form 8-K/A PRECIGEN, INC. For: Jan 31 -2.4%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: KIRK RANDAL J -2.4%
4/30 Precigen, Inc. (NASDAQ: PGEN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.4%
2/14 Form SC 13G PRECIGEN, INC. Filed by: MILLER VALUE PARTNERS, LLC -0.1%
3/2 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.250 ActVsEst (0.220) - Miss -17.1%
3/10 Form 4 PRECIGEN, INC. For: Mar 08 Filed by: Turley James S -7.6%
3/17 Precigen (NASDAQ: PGEN) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.8%
2/24 Precigen to Announce Fourth Quarter and Full Year 2019 Financial Results on March 2nd -4.6%
2/6 Form 8-K/A PRECIGEN, INC. For: Jan 31 -2.4%
4/2 Form 4 PRECIGEN, INC. For: Mar 31 Filed by: KIRK RANDAL J -2.4%
4/30 Precigen, Inc. (NASDAQ: PGEN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -1.4%
2/14 Form SC 13G PRECIGEN, INC. Filed by: MILLER VALUE PARTNERS, LLC -0.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: